DK2635596T3 - Immun-moduleringsmidler og anvendelser dertil - Google Patents

Immun-moduleringsmidler og anvendelser dertil Download PDF

Info

Publication number
DK2635596T3
DK2635596T3 DK11837324T DK11837324T DK2635596T3 DK 2635596 T3 DK2635596 T3 DK 2635596T3 DK 11837324 T DK11837324 T DK 11837324T DK 11837324 T DK11837324 T DK 11837324T DK 2635596 T3 DK2635596 T3 DK 2635596T3
Authority
DK
Denmark
Prior art keywords
immun
modulators
immun modulators
Prior art date
Application number
DK11837324T
Other languages
English (en)
Inventor
Sheila Donnelly
Mark William Robinson
John Pius Dalton
Joyce To
Original Assignee
Univ Sydney Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2010904873A external-priority patent/AU2010904873A0/en
Application filed by Univ Sydney Technology filed Critical Univ Sydney Technology
Application granted granted Critical
Publication of DK2635596T3 publication Critical patent/DK2635596T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0003—Invertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
    • C07K14/43559—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from trematodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK11837324T 2010-11-01 2011-11-01 Immun-moduleringsmidler og anvendelser dertil DK2635596T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2010904873A AU2010904873A0 (en) 2010-11-01 Immune-modulating agents and uses therefor
PCT/AU2011/001402 WO2012058715A1 (en) 2010-11-01 2011-11-01 Immune-modulating agents and uses therefor

Publications (1)

Publication Number Publication Date
DK2635596T3 true DK2635596T3 (da) 2019-11-25

Family

ID=46023860

Family Applications (1)

Application Number Title Priority Date Filing Date
DK11837324T DK2635596T3 (da) 2010-11-01 2011-11-01 Immun-moduleringsmidler og anvendelser dertil

Country Status (9)

Country Link
US (1) US11311610B2 (da)
EP (1) EP2635596B8 (da)
JP (2) JP2013545453A (da)
CN (1) CN103328499A (da)
AU (2) AU2011325857A1 (da)
BR (1) BR112013010926A2 (da)
CA (1) CA2816529A1 (da)
DK (1) DK2635596T3 (da)
WO (1) WO2012058715A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201806122YA (en) * 2016-02-01 2018-08-30 Univ Canberra Proteinaceous compounds and uses therefor
CN107919938B (zh) * 2016-10-10 2021-08-10 广州滴普科技有限公司 一种适用于OvXDM系统的信号采样恢复方法、装置及OvXDM系统
EP3756648A1 (en) * 2019-06-27 2020-12-30 Imnate Sarl Improved vaccine formulations

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1590574A (en) 1976-08-06 1981-06-03 Atomic Energy Authority Uk Biologically active gels
US4272398A (en) 1978-08-17 1981-06-09 The United States Of America As Represented By The Secretary Of Agriculture Microencapsulation process
US5417986A (en) 1984-03-16 1995-05-23 The United States Of America As Represented By The Secretary Of The Army Vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres
US4945050A (en) 1984-11-13 1990-07-31 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
ES2053549T3 (es) 1986-08-11 1994-08-01 Innovata Biomed Ltd Un proceso para la preparacion de una formulacion farmaceutica apropiada para inhalacion.
US5120657A (en) 1986-12-05 1992-06-09 Agracetus, Inc. Apparatus for genetic transformation
US4873192A (en) 1987-02-17 1989-10-10 The United States Of America As Represented By The Department Of Health And Human Services Process for site specific mutagenesis without phenotypic selection
US4857311A (en) 1987-07-31 1989-08-15 Massachusetts Institute Of Technology Polyanhydrides with improved hydrolytic degradation properties
DK0500785T3 (da) 1989-11-03 2002-08-19 Immulogic Pharma Corp Humant T-celleaktivitet felint protein (TRFP) isoleret fra husstøv samt anvendelser heraf
DE69133136T2 (de) 1990-05-16 2003-06-18 Southern Research Institute, Birmingham Mikrokapseln mit gesteuerter freigabe sowie deren verwendung zur stimulierung des nervenfaserwachstums
US5149655A (en) 1990-06-21 1992-09-22 Agracetus, Inc. Apparatus for genetic transformation
GB9016885D0 (en) 1990-08-01 1990-09-12 Scras Sustained release pharmaceutical compositions
WO1994024281A1 (en) 1993-04-14 1994-10-27 Immulogic Pharmaceutical Corporation T cell epitopes of the major allergens from dermatophagoides (house dust mite)
TW360548B (en) 1993-04-08 1999-06-11 Powderject Res Ltd Products for therapeutic use
US5457041A (en) 1994-03-25 1995-10-10 Science Applications International Corporation Needle array and method of introducing biological substances into living cells using the needle array
AU701440B2 (en) 1994-09-29 1999-01-28 Quadrant Drug Delivery Limited Spray-dried microparticles as therapeutic vehicles
AUPM873294A0 (en) 1994-10-12 1994-11-03 Csl Limited Saponin preparations and use thereof in iscoms
IL122290A0 (en) 1995-06-07 1998-04-05 Inex Pharmaceuticals Corp Lipid-nucleic acid complex its preparation and use
JP4322315B2 (ja) 1996-05-29 2009-08-26 デルシテク オサケ ユキチュア 生物学的適用のための溶解性酸化物
GB9619002D0 (en) 1996-09-11 1996-10-23 Oxford Biosciences Ltd Particle delivery
GB9612629D0 (en) 1996-06-17 1996-08-21 Oxford Biosciences Ltd Method for providing dense particle compositions for use in transdermal particle delivery
US7288266B2 (en) 1996-08-19 2007-10-30 United States Of America As Represented By The Secretary, Department Of Health And Human Services Liposome complexes for increased systemic delivery
US5783567A (en) 1997-01-22 1998-07-21 Pangaea Pharmaceuticals, Inc. Microparticles for delivery of nucleic acid
EP0888790A1 (en) 1997-07-04 1999-01-07 PowderJect Research Limited Drug particle delivery device
AUPP807899A0 (en) 1999-01-08 1999-02-04 University Of Queensland, The Codon utilization
WO1999002694A1 (en) 1997-07-09 1999-01-21 The University Of Queensland Nucleic acid sequence and method for selectively expressing a protein in a target cell or tissue
US6187335B1 (en) 1997-12-31 2001-02-13 Orasomal Technologies, Inc. Polymerizable fatty acids, phospholipids and polymerized liposomes therefrom
CA2321093A1 (en) 1998-02-20 1999-08-26 The Rockefeller University Apoptotic cell-mediated antigen presentation to dendritic cells
US6503231B1 (en) 1998-06-10 2003-01-07 Georgia Tech Research Corporation Microneedle device for transport of molecules across tissue
US6004815A (en) 1998-08-13 1999-12-21 The Regents Of The University Of California Bacteria expressing nonsecreted cytolysin as intracellular microbial delivery vehicles to eukaryotic cells
AU765957B2 (en) 1998-10-01 2003-10-02 Powderject Research Limited Spray coated microparticles for use in needleless syringes
IL142980A0 (en) 1998-11-05 2002-04-21 Powderject Vaccines Inc Nucleic acid constructs for genetic immunization
US20020004041A1 (en) 1999-02-19 2002-01-10 Albert Matthew L. Methods for abrogating a cellular immune response
ATE368011T1 (de) 1999-02-22 2007-08-15 Delsitech Oy Biologisch abbaubaren keramischen fasern aus kiselsäuresol
CA2370646A1 (en) 1999-04-21 2000-10-26 Powderject Vaccines, Inc. Nucleic acid immunization
AUPQ573300A0 (en) 2000-02-21 2000-03-16 Australian Nuclear Science & Technology Organisation Controlled release ceramic particles, compositions thereof, processes of preparation and methods of use
EP1282640A2 (en) 2000-05-01 2003-02-12 Powderject Vaccines, Inc. Nucleic acid immunization
IL153241A0 (en) 2000-06-08 2003-07-06 Powderject Vaccines Inc Powder compositions
WO2002019989A2 (en) 2000-09-08 2002-03-14 Powderject Research Limited Alginate particle formulation
AU2002241726A1 (en) 2000-11-02 2002-06-11 Powderject Vaccines, Inc. Compositions and therapeutical use of polynucleotides encoding tcrs
CA2449593A1 (en) 2001-06-08 2002-12-19 Powderject Vaccines, Inc. Spray freeze-dried compositions
EP1399132A1 (en) 2001-06-08 2004-03-24 Powderject Vaccines, Inc. Production of hard, dense particles
WO2004017943A2 (en) 2002-08-23 2004-03-04 Medigene Oncology Gmbh Non-vesicular cationic lipid formulations
WO2004067508A2 (en) 2003-01-24 2004-08-12 The Research Foundation Of State University Of Newyork Use of photodynamic therapy therapeutic agents entrapped in ceramic nanoparticles
US7923209B2 (en) 2003-03-14 2011-04-12 Anergis, S.A. Allergen peptide fragments and use thereof
WO2005023979A2 (en) * 2003-09-11 2005-03-17 Fundação De Amparo À Pesquisa Do Estado de São Paulo Isolated s. mansoni nucleic acid molecules and uses thereof
IL160033A0 (en) 2004-01-25 2004-06-20 Transpharma Medical Ltd Transdermal delivery system for polynucleotides
GB0402131D0 (en) 2004-01-30 2004-03-03 Isis Innovation Delivery method
US20050260260A1 (en) 2004-05-19 2005-11-24 Edward Kisak Liposome compositions for the delivery of macromolecules
EP1868562A1 (en) 2005-03-04 2007-12-26 Altairnano, Inc Ceramic structures for controlled release of biologically active substances
CN1683403A (zh) 2005-03-11 2005-10-19 中山大学 日本血吸虫细胞周期静止素，其编码核酸及其应用

Also Published As

Publication number Publication date
US11311610B2 (en) 2022-04-26
WO2012058715A1 (en) 2012-05-10
EP2635596B8 (en) 2020-03-11
CN103328499A (zh) 2013-09-25
EP2635596A1 (en) 2013-09-11
CA2816529A1 (en) 2012-05-10
US20130287806A1 (en) 2013-10-31
EP2635596B1 (en) 2019-09-04
AU2016202731A1 (en) 2016-05-19
EP2635596A4 (en) 2014-07-02
JP2013545453A (ja) 2013-12-26
JP2017131234A (ja) 2017-08-03
AU2016202731B2 (en) 2018-10-25
AU2011325857A1 (en) 2013-05-02
BR112013010926A2 (pt) 2016-08-23

Similar Documents

Publication Publication Date Title
DK2648742T3 (da) Formuleringer indeholdende saponiner og anvendelser deraf
DK3339323T3 (da) Anti-n3pglu-amyloid-beta-peptid-antistoffer og anvendelser deraf
DK2914291T3 (da) Anti-komplement-c1s-antistoffer og anvendelser deraf
DK2920197T3 (da) Prolinlåste sammenhæftede peptider og anvendelser deraf
DK2906684T3 (da) T-celle-modificerende forbindelser og anvendelser deraf
DK3597644T3 (da) Kationiske aminlipider og anvendelser deraf
DK3346008T3 (da) Rekombinante mikroorganismer og anvendelser deraf
DK2552434T3 (da) Peptider og anvendelse deraf
DK2624567T3 (da) Blokinddelingsfremgangsmåde og afkodningsindretning
DK3664453T3 (da) Billedforudsigelse-afkodningsindretning og billedforudsigelse-afkodningsfremgangsmåde
DK2643522T3 (da) Broanordning
DK2544719T3 (da) Cd37-bindingsmolekyler og immunkonjugater deraf
DK3415157T3 (da) N-acyldipeptidderivater og anvendelser deraf
DK3197164T3 (da) Afkodningsanordning og afkodningsfremgangsmåde
DK2596488T3 (da) Reklameindretning
DK2600715T3 (da) Flydende ST-246-formuleringer og fremgangsmåder
DK2353927T3 (da) Forankrings-system og indretninger
DK2917181T3 (da) Heteroarylderivater og anvendelser deraf
DK3453723T3 (da) Anti-ASIC1-antistoffer og anvendelser deraf
DK2642992T3 (da) Forbindelser og anvendelse deraf
BR112013009579A2 (pt) método e comprimido
DK2745849T3 (da) Polydeoxyribonukleotidsammensætning og anvendelser deraf
DK2704744T3 (da) Komplementfaktor-b-analoger og anvendelser deraf
DK2252688T3 (da) Syntetiske phosphodiester-oligonukleotider og terapeutiske anvendelser deraf
FI20105906A0 (fi) Laite